IL-6: from its discovery to clinical applications (Q37735571)

22 August 2017

1 reference

title

IL-6: from its discovery to clinical applications (English)

1 reference

22 August 2017

Tadamitsu Kishimoto

1

1 reference

22 August 2017

21 April 2010

1 reference

22 August 2017

International Immunology

1 reference

22 August 2017

22

1 reference

22 August 2017

347-352

1 reference

22 August 2017

5

1 reference

Interleukin-6: from basic science to medicine--40 years in immunology

22 August 2017

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXQ030

Cloning and expression of the human interleukin-6 (BSF-2/IFN beta 2) receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXQ030

Molecular cloning and expression of an IL-6 signal transducer, gp130

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXQ030

Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXQ030

Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXQ030

A new protein containing an SH2 domain that inhibits JAK kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXQ030

Structure and function of a new STAT-induced STAT inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXQ030

A family of cytokine-inducible inhibitors of signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXQ030

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXQ030

Transforming growth factor-beta induces development of the T(H)17 lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXQ030

Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXQ030

Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXQ030

Cell to cell interaction in the immune response. I. Hemolysin-forming cells in neonatally thymectomized mice reconstituted with thymus or thoracic duct lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXQ030

Factors affecting B-cell growth and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXQ030

Induction of IgG production in human B lymphoblastoid cell lines with normal human T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXQ030

Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXQ030

IgG1 plasmacytosis in interleukin 6 transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXQ030

Generation of plasmacytomas with the chromosomal translocation t(12;15) in interleukin 6 transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXQ030

Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXQ030

Impaired immune and acute-phase responses in interleukin-6-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXQ030

The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXQ030

CNTF and LIF act on neuronal cells via shared signaling pathways that involve the IL-6 signal transducing receptor component gp130

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXQ030

Cardiotrophin-1. Biological activities and binding to the leukemia inhibitory factor receptor/gp130 signaling complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXQ030

IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXQ030

Critical cytoplasmic region of the interleukin 6 signal transducer gp130 is conserved in the cytokine receptor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXQ030

Interferon-induced nuclear signalling by Jak protein tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXQ030

Structure of the murine Jak2 protein-tyrosine kinase and its role in interleukin 3 signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXQ030

Acute-phase response factor, a nuclear factor binding to acute-phase response elements, is rapidly activated by interleukin-6 at the posttranslational level

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXQ030

Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXQ030

Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSFp-2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXQ030

Interleukin 6 plays a key role in the development of antigen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXQ030

Aryl hydrocarbon receptor regulates Stat1 activation and participates in the development of Th17 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXQ030

Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXQ030

The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXQ030

Dioxin receptor is a ligand-dependent E3 ubiquitin ligase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXQ030

Aryl hydrocarbon receptor in combination with Stat1 regulates LPS-induced inflammatory responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXQ030

Induction of Plasma-Cell Neoplasms in Strain BALB/c Mice with Mineral Oil and Mineral Oil Adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXQ030

21 January 2018

Identifiers

DOI

10.1093/INTIMM/DXQ030

1 reference

22 August 2017

1 reference

PubMed ID

20410258